# Role of Epidermal Growth Factor (EGF) in Development of Necrotizing Enterocolitis

> **NCT00059449** · — · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 372 (estimated)

## Conditions studied

- Necrotizing Enterocolitis
- Premature Birth

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00059449
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 372 (ESTIMATED)
- **Last updated:** 2010-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00059449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00059449, "Role of Epidermal Growth Factor (EGF) in Development of Necrotizing Enterocolitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00059449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*